An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters
Clinical trial NCT01112345 · COMPLETED
Trial details
- NCT number
- NCT01112345
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.